tiprankstipranks
Trending News
More News >
Mannkind Corp. (MNKD)
NASDAQ:MNKD

Compare MannKind (MNKD) vs. Competitors

Compare
2,058 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
MannKind
$2.44
$751.77M
-27.17
-53.26%
6 Buy
1 Hold
0 Sell
Strong Buy
BioCryst
$9.80
$2.46B
6.20
22.81%
8 Buy
0 Hold
0 Sell
Strong Buy
Celldex
$31.80
$2.12B
-6.98
61.91%
10 Buy
1 Hold
1 Sell
Strong Buy
Sarepta Therapeutics
$17.71
$1.86B
-3.16
-76.10%
6 Buy
11 Hold
4 Sell
Hold
Cogent Biosciences
$35.41
$5.75B
-7.30
394.55%
10 Buy
2 Hold
0 Sell
Strong Buy
Immunocore Holdings
$30.35
$1.54B
1.81%
6 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MNKD
MannKind
2.44
-2.79
-53.35%
BCRX
BioCryst
9.80
1.75
21.74%
CLDX
Celldex
31.80
11.02
53.03%
SRPT
Sarepta Therapeutics
17.71
-58.62
-76.80%
COGT
Cogent Biosciences
35.41
28.01
378.51%
IMCR
Immunocore Holdings
30.35
0.71
2.40%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts